Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay

BACKGROUND: The coronavirus disease 2019 (COVID-19) endgame may benefit from simple, accurate antibody testing to characterize seroprevalence and immunization coverage. OBJECTIVES: To evaluate the performance of the lateral flow QIAreach anti-SARS-CoV-2 Total rapid nanoparticle fluorescence immunoas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibai, Mamdouh, Solis, Daniel, Röltgen, Katharina, Stevens, Bryan A., Mfuh, Kenji O., Sahoo, Malaya K., Shi, Run Z., Zehnder, James, Boyd, Scott D., Pinsky, Benjamin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015349/
https://www.ncbi.nlm.nih.gov/pubmed/33932848
http://dx.doi.org/10.1016/j.jcv.2021.104818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015349/
https://www.ncbi.nlm.nih.gov/pubmed/33932848
http://dx.doi.org/10.1016/j.jcv.2021.104818

Ejemplares similares